Jimmy Zhang, Ph.D, MBA, is a Venture Partner with Lilly Asia Ventures (LAV). Jimmy was Vice President, Transactions, Johnson & Johnson Innovation. He led the transactional and partnership management activities and strategy in Asia Pacific region in pharmaceuticals, medical devices & diagnostics and consumer products, as well as fund relationship and partnership. Jimmy was the Managing Director, MSD Early Investments – Greater China at Merck & Co., and a member of Merck Research Lab (China) Senior Leadership Team. He was also a Board Director of BeiGene (Beijing) Co, Ltd. and an Advisor Board member of Cenova Ventures. Jimmy was previously SVP at Synergenics, a consultant at McKinsey & Company, a registered patent agent in the Palo Alto office of Morrison & Foerster, and a project manager at Chiron Corporation (now part of Novartis). Currently, Jimmy is also a professor in Pharmaceutical Management and master student mentor in Shenyang Pharmaceutical University. Jimmy received his B.S. in biochemistry from Nanjing University, and Ph.D. in biomedical sciences from University of Texas Southwestern Medical Center at Dallas, and MBA from MIT Sloan School of Management. Jimmy published in Cell, Nature, Neuron, and JBC, and holds multiple patents.